• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    85.97 Up 0.18(0.21%) Feb 12, 4:00PM EST
    |After Hours : 85.99 Up 0.02 (0.02%) Feb 12, 5:07PM EST
    Prev Close:85.79
    Open:86.79
    Bid:85.00 x 100
    Ask:N/A
    1y Target Est:122.50
    Beta:0.908519
    Earnings Date:May 9 - May 13 (Est.)
    Day's Range:84.54 - 87.06
    52wk Range:54.92 - 114.00
    Volume:562,155
    Avg Vol (3m):391,392
    Market Cap:1.71B
    P/E (ttm):7.09
    EPS (ttm):12.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    LGNDUp 0.21%1.71B
    MRKUp 0.37%136.97B
    LLYDown 0.21%75.47B

    Key Statistics

    Forward P/E (1 yr):17.58
    P/S (ttm):23.78
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-16) :3.24
    Quarterly EPS Est (Mar-16) :0.61
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):0.58

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback